Login to Your Account

Mixiii-Biomed 2018

Exploit the luck of approved drugs with more systematic repurposing

By Alfred Romann
Staff Writer

Wednesday, May 16, 2018

TEL AVIV – Industrializing "luck" may open the door to a motherlode that the biopharmaceutical industry may be currently ignoring. One path to faster drug development, said Daphna Leifenfeld, is repurposing of existing drugs. This not only makes sense, but is something that the pharmaceutical industry should do more of, she said at the 17th Mixiii-Biomed Conference this week. The meeting in Israel is focused on trends shaping the future of health care systems and life sciences.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription